04Jun
Cannabis-Derived Ingredients in FDA-Regulated Products: More Questions than Answers at FDA’s May 2019 Public Hearing
As most folks with any interest in the burgeoning cannabidiol (CBD) industry likely know, on May 31, 2019, the Food and Drug Administration held a public hearing “to obtain scientific data and information about the safety, manufacturing, product...
By:
Mintz - Consumer Product Safety Viewpoints
Related
In these pages, we recently wrote about the passage of several bills of great import from the recent...
Read More >
The EEOC announced that it reached a $74,418 settlement with a hospital in Owosso, Michigan, to sett...
Read More >
Attention hospitality employers. Is that charge you add to a guest check a service charge (typicall...
Read More >
In recent months, we have had several situations where clients were assessed back wages for overtime...
Read More >
Jurisdictions Limiting Construction Work - Massachusetts: Construction generally is allowed in Massa...
Read More >
The Empire State Development Corporation (“ESDC”) issued guidance over the weekend clarifying the ...
Read More >